Research training interests of the Division of Heart and Vascular Diseases of the National Heart, Lung, and Blood Institute.

1983 ◽  
Vol 2 (5, Suppl) ◽  
pp. 63-65
Author(s):  
Donald MacCanon
Keyword(s):  
Research Training ◽  
Vascular Diseases ◽  
Blood Institute ◽  
National Heart ◽  
National Heart Lung

scholarly journals The National Heart, Lung, and Blood Institute Strategic Vision Implementation for Health Equity Research

2019 ◽  
Vol 29 (Suppl 1) ◽  
pp. 57-64 ◽  
Author(s):  
George A. Mensah ◽  
Catherine M. Stoney ◽  
Michelle M. Freemer ◽  
Sharon Smith ◽  
Michael M. Engelgau ◽  
...  
Keyword(s):  
Health Equity ◽  
Predictive Analytics ◽  
Research Training ◽  
Blood Diseases ◽  
Blood Institute ◽  
Strategic Vision ◽  
National Heart ◽  
Equity Research ◽  
National Heart Lung ◽  
Health Equity Research

The National Heart, Lung, and Blood Institute (NHLBI) provides global leader­ship for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood diseases and enhance the health of all individuals so that they can live longer and more fulfilling lives. Inherent in this mission is the com­mitment to advance health equity research as an avenue for enhancing the health of all individuals. Additionally, the four goals and eight research objectives of the NHLBI Strategic Vision directly support the com­mitment to health equity. In this article, we present selected examples of the NHLBI Strategic Vision implementation approaches for advancing health equity research in our mission areas of heart, lung, and blood diseases. Examples of diseases for which the burden of health inequities and our strategic vision implementation approaches are discussed include hypertension, heart failure, vascular dementia, asthma, and sickle cell disease. Examples are provided of new avenues of Institute-solicited re­search to stimulate and address compelling scientific questions and critical challenges to advance health equity. We also highlight the emerging fields of implementation sci­ence and predictive analytics as important opportunities to accelerate the translation of discovery science into health impact for all and to advance health equity.Ethn Dis.2019;29(Suppl1):57-64; doi:10.18865/ed.29.S1.57.

Diagnosis and Treatment of Right Heart Failure in Pulmonary Vascular Diseases: A National Heart, Lung, and Blood Institute Workshop

2021 ◽  
Vol 14 (6) ◽  
Author(s):  
Jane A. Leopold ◽  
Steven M. Kawut ◽  
Micheala A. Aldred ◽  
Stephen L. Archer ◽  
Ray L. Benza ◽  
...  
Keyword(s):  
Vascular Diseases ◽  
Right Ventricular Dysfunction ◽  
Right Heart Failure ◽  
Pulmonary Vascular Disease ◽  
Blood Institute ◽  
National Heart ◽  
National Heart Lung ◽  
Underlying Mechanisms ◽  
The Right

Right ventricular dysfunction is a hallmark of advanced pulmonary vascular, lung parenchymal, and left heart disease, yet the underlying mechanisms that govern (mal)adaptation remain incompletely characterized. Owing to the knowledge gaps in our understanding of the right ventricle (RV) in health and disease, the National Heart, Lung, and Blood Institute commissioned a working group to identify current challenges in the field. These included a need to define and standardize normal RV structure and function in populations; access to RV tissue for research purposes and the development of complex experimental platforms that recapitulate the in vivo environment; and the advancement of imaging and invasive methodologies to study the RV within basic, translational, and clinical research programs. Specific recommendations were provided, including a call to incorporate precision medicine and innovations in prognosis, diagnosis, and novel RV therapeutics for patients with pulmonary vascular disease.

Sign in / Sign up

Export Citation Format

Share Document